Biosensors Market Report 2026

The biosensors market size has grown rapidly in recent years. It will grow from $38.17 billion in 2025 to $42.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growth in clinical diagnostic testing, increasing adoption of glucose monitoring devices, expansion of biotechnology research activities, demand for rapid pathogen detection.

The biosensors market size is expected to see strong growth in the next few years. It will grow to $61.07 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growth in personalized medicine adoption, increasing deployment of wearable health devices, rising demand for remote patient monitoring, expansion of biosensors in environmental monitoring, technological advancements in nanotechnology-based sensors. Major trends in the forecast period include wearable biosensor integration in personal health, point-of-care biosensing for rapid diagnostics, miniaturization of biosensor devices, multi-analyte detection platforms, enhanced sensitivity and selectivity in biosensors.

The rising prevalence of chronic disorders is expected to drive the growth of the biosensors market. Chronic disorders are long-term medical conditions that persist over time and often require continuous management and treatment to control symptoms and maintain quality of life. Their increasing prevalence is linked to factors such as sedentary lifestyles, unhealthy eating habits, genetic factors, and exposure to environmental pollutants. Biosensors support the management of chronic disorders by enabling early detection and continuous monitoring of biomarkers, significantly improving disease monitoring and patient outcomes. For instance, in July 2023, the Health Foundation, a UK-based nonprofit organization, projected that by 2040, approximately 9.1 million people in England would be living with major illnesses, an increase of 2.5 million compared to current levels. Therefore, the rising prevalence of chronic disorders is contributing to the expansion of the biosensors market.

Major companies in the biosensors market are prioritizing the development of advanced technologies, such as graphene barristor sensors, to enhance detection sensitivity, improve signal amplification, and deliver faster, more accurate biomolecule sensing for medical and environmental applications. A graphene barristor sensor is a graphene-silicon hybrid device that utilizes a Schottky barrier to detect electrical changes triggered by biomolecular interactions, offering highly sensitive and rapid biosensing capabilities. For example, in December 2024, Versarien plc, a UK-based advanced engineering materials company, introduced a new graphene biosensor chip. Built on a graphene barristor sensor platform - a graphene-silicon Schottky-barrier triode device - the chip provides more than a 10,000-fold improvement in current modulation compared to traditional graphene field-effect transistors (GFETs). Its graphene surface is functionalized with pyrenebutanoic acid succinimidyl ester (PBASE) or a customer-specified linker, enabling the attachment of bio-recognition elements for precise biosensing applications.

In February 2023, Miltenyi Biotec, a Germany-based biotechnology company, acquired Lino Biotech AG for an undisclosed sum. Through this acquisition, Miltenyi Biotec intends to leverage Lino's innovative biosensor platform to enhance cell-gene therapy approaches, reduce costs, and set a new standard for potency assays. Lino Biotech AG, headquartered in Switzerland, specializes in innovative biosensor technologies for applications in the life sciences and healthcare sectors.

Major companies operating in the biosensors market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies, Illumina Inc., Sartorius AG, BioMérieux SA, Cytiva, PerkinElmer Inc., Sysmex Corporation, Dexcom Inc., Bio-Rad Laboratories, Bruker Corporation, HORIBA Ltd., Lifescan Inc., Nova Biomedical, Bio-Techne Corporation, Sensirion AG, Proteus Digital Health, Acon Laboratories Inc., 908 Devices Inc.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have influenced the biosensors market by increasing costs associated with imported electronic components, microchips, and specialized materials used in sensor fabrication. These impacts are most evident in medical diagnostics and wearable biosensor segments, particularly in Asia-Pacific and North America where manufacturing and R&D activities are concentrated. Higher tariffs have led to pricing pressures and extended development timelines for biosensor devices. However, tariffs have also encouraged local manufacturing initiatives and regional supply chain development, supporting long-term market stability and innovation.

The biosensors market research report is one of a series of new reports that provides biosensors market statistics, including biosensors industry global market size, regional shares, competitors with a biosensors market share, detailed biosensors market segments, market trends and opportunities, and any further data you may need to thrive in the biosensors industry. This biosensors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A biosensor represents a compact analytical tool with the capability to detect and quantify biological substances or changes. Its applications span across various sectors, encompassing healthcare, environmental monitoring, and food safety. Biosensors primarily serve the purpose of swiftly and sensitively detecting specific biological substances or processes, facilitating their utilization in diverse fields such as healthcare diagnostics, environmental surveillance, food safety assessment, and industrial bioprocess control.

The principal types of biosensors include wearable and non-wearable variants. Wearable biosensors are portable devices worn on the body, designed to monitor health parameters such as heart rate and activity levels, thereby offering real-time data for individual health and fitness management. Various technologies such as electrochemical, optical, piezoelectric, nanomechanical, and thermal biosensors are employed across applications ranging from medical diagnostics to food toxicity assessment, bioreactor monitoring, agricultural applications, environmental analysis, and beyond.North America was the largest region in the biosensors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosensors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biosensors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biosensors market consists of revenues earned by entities by providing biosensor technologies and related services, including installation, calibration, maintenance, and support for biosensor systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosensors market also includes sales of various types of biosensor devices, such as gas biosensors, DNA biosensors, smartphone-based biosensors, and implantable biosensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.